GTR 118477968
Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From November 1St, 2026 To Usually October 31St, 2028
ICB — International Competitive Bid
Closes Oct 08, 2026
Western Europe
Tender Information
GTR Reference
118477968
Tendering Authority
Subscribe to view
Tender No
654992-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From November 1St, 2026 To Usually October 31St, 2028
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
08-10-2026
Work Detail
Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From November 1St, 2026 To Usually October 31St, 2028. Active Ingredient Ublituximab; Atc Code L04ag14; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Teriparatide; Atc Code H05aa02; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Pasireotide; Atc Code H01cb05; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Octreotide; Atc Code H01cb02; Dosage Form Trs, Dfl And Pen; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Mercaptamine; Atc Code A16aa04; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Macrogol, Combinations; Atc Code A06ad65; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Lipegfilgrastim, Combinations; Atc Code L03aa14; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Epoetin Alfa, Combinations; Atc Code B03xa01; Dosage Form Ife Only 1,000 Iu Up To And Including 10,000 Iu; Potency See Dosage Form; Pack Size All (Excluding Clinical Packs),Active Ingredient Epoetin Alfa, Combinations; Atc Code B03xa01; Dosage Form Everything Except Ife 1,000 Iu Up To And Including 10,000 Iu; Potency See Dosage Form; Pack Size All (Excluding Clinical Packs),Active Ingredient Elafibranor, Combinations; Atc Code A05ax06; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Efbemalenograstim Alfa, Combinations; Atc Code L03aa18; Dosage Form Solution For Injection; Potency 20 Mg; Pack Size All (Excluding Clinical Packs),Active Ingredient Dornase Alfa, Combinations; Atc Code R05cb13; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Edoxaban, Combinations; Atc Code B01af03; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs)
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
6d822f95-12f9-464c-b5dd-7d6ed2ab3671.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.